Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01642121 · ClinicalTrials.gov registry record

Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia

A clinical trial of Childhood Acute Monoblastic Leukemia (M5a) and Childhood Acute Monocytic Leukemia (M5b), sponsored by Children's Oncology Group.

Completed
Registry status
20
Enrollment target
1
Study location

NCT01642121 is a study of Childhood Acute Monoblastic Leukemia (M5a) and Childhood Acute Monocytic Leukemia (M5b) that has completed, run by Children's Oncology Group. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01642121, a study of Childhood Acute Monoblastic Leukemia (M5a) and Childhood Acute Monocytic Leukemia (M5b), has completed, sponsored by Children's Oncology Group.

COMPLETED
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

This laboratory study is looking into biomarkers in samples from younger patients with acute myeloid leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer

Interventions

  • OTHER laboratory biomarker analysis

Study Locations (1)

California

  • Children's Oncology Group - Monrovia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-08

Sponsor

Children's Oncology Group

342 total trials

What the Registry Record Tells You About NCT01642121

The ClinicalTrials.gov registry entry for NCT01642121 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Childhood Acute Monoblastic Leukemia (M5a) appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.

NCT01642121 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01642121 about?

NCT01642121 is a clinical study titled "Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia". This laboratory study is looking into biomarkers in samples from younger patients with acute myeloid leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer

What is the current status of trial NCT01642121?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-08.

What conditions does trial NCT01642121 study?

This clinical trial studies the following conditions: Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies.

What interventions are being tested in trial NCT01642121?

The interventions under investigation include: laboratory biomarker analysis (OTHER).

Who is sponsoring clinical trial NCT01642121?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01642121 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Acute Monoblastic Leukemia (M5a)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.